Accord Healthcare, Inc.: Drug Recall
Recall #D-0405-2023 · 02/07/2023
Class II: Risk
Recall Details
- Recall Number
- D-0405-2023
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Accord Healthcare, Inc.
- Status
- Terminated
- Date Initiated
- 02/07/2023
- Location
- Durham, NC, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 56,862 bottles
Reason for Recall
CGMP Deviations: recalling drug products following an FDA inspection.
Product Description
Rosuvastatin Tablets, USP, 10 mg*, Rx Only, Packaged as: a) 90-count bottle, NDC 16729-285-15, UPC 3 16729 28515 5; b) 1,000-count bottle NDC 16729-285-17, UPC 3 16729 28517 9; Manufactured for: Accord Healthcare, Inc., Durham, NC 27703. Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213 INDIA
Distribution Pattern
United States including Puerto Rico and Canada
Other Recalls by Accord Healthcare, Inc.
- Class II: Risk 09/16/2025
- Class II: Risk 06/20/2025
- Class II: Risk 06/20/2025
- Class II: Risk 06/20/2025
- Class II: Risk 06/20/2025
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.